Biomind Labs Inc. Logo

Biomind Labs Inc. (BMND)

NEO

Currency in CAD
0.6900
+0.10 (+16.95%)

Real-time Data

01:30 PM

Day's Range

0.3600
0.6900

52 wk Range

0.01000
0.8000

Overview - BMND - Biomind Labs Inc.

Key Statistics

Valuation

Enterprise Value

75.75M

P/E (Trailing)

‪-68.99‬

Price / Book

‪-29.51‬

EV / EBITDA

‪-66.94‬

Profitability

Profit Margin

‪0.00%‬

Operating Margin

‪0.00%‬

Return on Assets

‪-2,859.18%‬

Return on Equity

‪48.99%‬

Ownership

Shares Outstanding

77.57M

Float

49.40M

Held by Insiders

‪36.31%‬

Held by Institutions

‪0.00%‬

Price stats

Beta

‪7.28‬

50-Day Avg

‪0.1381‬

200-Day Avg

‪0.1650‬

Dividends

Payout Ratio

‪0.00%‬

News Teaser - BMND - Biomind Labs Inc.

News & Analysis

View all news

Market Cap - BMND - Biomind Labs Inc.

Profile Summary - BMND - Biomind Labs Inc.

About

Biomind Labs Inc. is a cutting-edge biotechnology company primarily focused on exploring and developing novel therapeutics for neurological and mental health disorders. As part of the burgeoning field of psychopharmacology, Biomind Labs is at the forefront of researching psychedelic compounds, aiming to harness their…

SectorHealthcare
IndustryBiotechnology
Employees5
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.